US SB4741 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 23 2024 - 25% progression
Action: 2024-07-23 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Status: Introduced on July 23 2024 - 25% progression
Action: 2024-07-23 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Summary
A bill to amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.
Title
A bill to amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.
Sponsors
Sen. Thom Tillis [R-NC] | Sen. Mark Kelly [D-AZ] |
History
Date | Chamber | Action |
---|---|---|
2024-07-23 | Senate | Read twice and referred to the Committee on Finance. |
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/senate-bill/4741/all-info |